Inventor
TSUNODA HIROYUKI
JP32 patents
⚠️ This page may combine multiple inventors who share the name “TSUNODA HIROYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
15 patentsUS9828429B2Nov 28, 2017
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD40 citations98
US7919086B2Apr 5, 2011
Anti-glypican 3 antibody
CHUGAI PHARMACEUTICAL CO LTD74 citations96
US11248053B2Feb 15, 2022
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD16 citations94
US11168344B2Nov 9, 2021
Methods for producing polypeptides by regulating polypeptide association
CHUGAI PHARMACEUTICAL CO LTD18 citations94
US10934344B2Mar 2, 2021
Methods of modifying antibodies for purification of bispecific antibodies
CHUGAI PHARMACEUTICAL CO LTD19 citations94
US10662245B2May 26, 2020
Methods of reducing IL-6 activity for disease treatment
CHUGAI PHARMACEUTICAL CO LTD22 citations94
US9399680B2Jul 26, 2016
Nucleic acids encoding anti-NR10 antibodies
CHUGAI PHARMACEUTICAL CO LTD17 citations91
US12122840B2Oct 22, 2024
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD5 citations86
US12116414B2Oct 15, 2024
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
CHUGAI PHARMACEUTICAL CO LTD5 citations86
US8034903B2Oct 11, 2011
Degraded TPO agonist antibody
CHUGAI PHARMACEUTICAL CO LTD8 citations83
US8008073B2Aug 30, 2011
Anti-Mpl antibodies
CHUGAI PHARMACEUTICAL CO LTD12 citations83
US7993642B2Aug 9, 2011
Anti-MPL antibodies
CHUGAI PHARMACEUTICAL CO LTD11 citations83
US7709615B2May 4, 2010
Polynucleotides encoding anti-ganglioside antibodies
CHUGAI PHARMACEUTICAL CO LTD11 citations82
US9556264B2Jan 31, 2017
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
CHUGAI PHARMACEUTICAL CO LTD5 citations70
US12473375B2Nov 18, 2025
Methods for controlling blood pharmacokinetics of antibodies
CHUGAI PHARMACEUTICAL CO LTD0 citations62
IGAWA TOMOYUKI
7 patentsUS9096651B2Aug 4, 2015
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
IGAWA TOMOYUKI90 citations99
US10011858B2Jul 3, 2018
Methods for producing polypeptides by regulating polypeptide association
IGAWA TOMOYUKI67 citations98
US8562991B2Oct 22, 2013
Antibody molecules that bind to IL-6 receptor
IGAWA TOMOYUKI130 citations98
US11046784B2Jun 29, 2021
Methods for controlling blood pharmacokinetics of antibodies
IGAWA TOMOYUKI24 citations94
US9670269B2Jun 6, 2017
Methods of modifying antibodies for purification of bispecific antibodies
IGAWA TOMOYUKI43 citations94
US8497355B2Jul 30, 2013
Anti-glypican-3 antibody having improved kinetics in plasma
IGAWA TOMOYUKI29 citations92
US9493569B2Nov 15, 2016
Structural isomers of sc(Fv)2
IGAWA TOMOYUKI7 citations82